Search results
UK pharma group reprimands Novo Nordisk for undisclosed payments
Pharmaceutical Technology· 5 days agoThe Association of the British Pharmaceutical Industry (ABPI) has pulled up four pharmaceutical...
Future Female Forward: Pfizer India's Nevatia urges women to assert their worth for equal pay - CNBC...
CNBC TV18· 3 days agoNevatia highlighted that while diversity is a broad goal, gender diversity is a critical and urgent pillar within it for Pfizer. However, she noted that despite progress in ...
Healthcare stocks edge lower
Business Standard India· 3 days agoHealthcare stocks were trading in red, with the BSE Healthcare index decreasing 176.56 points or 0.46% at 38397.74 at 13:47 IST.
Eli Lilly to buy bowel disease drug developer Morphic for $3.2 bln - ET HealthWorld | Pharma
The Economic Times· 6 days agoLondon: Eli Lilly will acquire Morphic Holding for $3.2 billion in cash, the companies said on...
Moneycontrol Pro Panorama | Pharma companies step up R&D spends to climb product ladder
CNBC Awaaz· 5 days agoThe Panorama newsletter is sent to Moneycontrol Pro subscribers on market days. It offers easy...
Should investors hold Emcure Pharma for long term? Sneha Poddar answers
The Economic Times· 4 days agoCan you tell us a little bit more about the business of Emcure Pharma? Sneha Poddar: So, Emcure is...
Mumbai's Bandra Kurla Complex: All About Anant Ambani-Radhika Merchant's Wedding Venue
Times Now· 2 days agoBandra-Kurla Complex (BKC) is one of the key areas for which MMRDA is the "Special Planning...
Quant Small Cap Fund sells 8.3 lakh shares of LIC, exits Adani Green Energy - The Economic Times
The Economic Times· 6 days agoQuant Small Cap Fund adjusts its portfolio in June with notable changes in stakes for Adani Power,...
Ashwani Gandhi appointed CEO of Niraamaya Life - ET HospitalityWorld
The Economic Times· 2 days agoWith over 18 years of experience, he brings a strong background in the digital space, having worked...
iOnctura expands PI3K inhibitor programme to NSCLC
Pharmaceutical Technology· 4 days agoRoche made a recent advancement in the space, securing FDA priority review in breast cancer for the PI3K inhibitor inavolisib as a combination therapy...